Results 101 to 110 of about 53,966 (218)
Swan syndrome refers to delayed recurrent intraocular bleeding caused by vascular ingrowth at the site of a prior surgical wound. Although classically described after cataract surgery, it has rarely been reported following trabeculectomy. We report three
Priyanka Sudhakar +2 more
doaj +1 more source
Masayasu Kitahashi,1 Takayuki Baba,1 Madoka Sakurai,1 Hirotaka Yokouchi,1 Mariko Kubota-Taniai,1 Yoshinori Mitamura,2 Shuichi Yamamoto1 1Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, 2Institute of ...
Yokouchi H +6 more
core
Risk ratio of systemic adverse events associated with intravitreal bevacizumab compared with ranibizumab.
Xiulan Zhang (142434), Wei Wang (17594)
core +1 more source
Tadanobu Yoshikawa, Kanji Takahashi Department of Ophthalmology, Kansai Medical University, Osaka, Japan Purpose: To describe the outcomes of intravitreal injections of bevacizumab for choroidal neovascularization (CNV) associated with choroidal ...
Yoshikawa T, Takahashi K
core
Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy
Ashraf M El-BatarnyAssistant Professor of Ophthalmology, Tanta University, Egypt; Chief of Vitreoretinal Service, Magrabi Eye and Ear Hospital, Muscat, Sultanate of OmanPurpose: To evaluate the effect of intravitreal injection of Avastin, bevacizumab ...
Ashraf M El-Batarny
core
Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab
To evaluate the course of treatment and outcomes of neovascular glaucoma (NVG) treated with intravitreal bevacizumab. The study is a retrospective, non-comparative, consecutive, interventional case series.
Palmberg, P F +4 more
core +1 more source
Intravitreal bevacizumab for management of choroidal osteoma without choroidal neovascularization
To report a patient with juxtapapillary choroidal osteoma (CO) with serous retinal detachment (SRD) not associated with choroidal neovascularization (CNV) who was successfully treated with a single intravitreal injection of bevacizumab.
Seyyed Moien Hendimarjan +3 more
core +1 more source
Aflibercept monotherapy or bevacizumab first for diabetic macular edema
Purpose: Clinical outcome and switch patterns with bevacizumab first treatment strategy for patients with newly diagnosed neovascular age-related macular degeneration (nAMD).
Avner Hostovsky +2 more
doaj +1 more source
Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
Sohee Jeon, Won Ki LeeDepartment of Ophthalmology, Seoul St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, KoreaBackground: We evaluated the efficacy of intravitreal bevacizumab on diabetic macular edema with ...
Jeon S, Lee WK
core
Management of Ruptured Retinal Arterial Macroaneurysm with Intravitreal Bevacizumab
The authors report the management of a ruptured retinal arterial macroaneurysm and associated hemorrhages with intravitreal injections of bevacizumab. A 79-year-old woman presented with a history of systemic arterial hypertension and a ruptured retinal ...
Golnaz Javey +5 more
core +1 more source

